Clinical Trials Related to Progressive Supranuclear Palsy

Related studies linked through entity extraction aliases.

Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy

Status: COMPLETED
Phase: NA

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

Status: COMPLETED
Phase: PHASE1/PHASE2

Diagnostic and Prognostic Biomarkers in Parkinson Disease

Status: UNKNOWN
Phase: N/A

A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy.

Status: COMPLETED
Phase: NA

Effects of Coenzyme Q10 in PSP and CBD

Status: COMPLETED
Phase: PHASE2/PHASE3

Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy

Status: UNKNOWN
Phase: PHASE2

Research of Biomarkers in Parkinson Disease

Status: COMPLETED
Phase: N/A

Risk Factors for Progressive Supranuclear Palsy (PSP)

Status: COMPLETED
Phase: N/A

Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)

Status: COMPLETED
Phase: PHASE2

Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)

Status: COMPLETED
Phase: NA

Study About Safety and Efficacy of Coenzyme Q10 in Progressive Supranuclear Palsy

Status: COMPLETED
Phase: PHASE2

Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS)

Status: TERMINATED
Phase: PHASE3

Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy

Status: COMPLETED
Phase: PHASE2